Evidence mapPaperPMID 36982879Full record

ReviewInternational journal of molecular sciences2023

The Central Noradrenergic System in Neurodevelopmental Disorders: Merging Experimental and Clinical Evidence.

Alessandro Galgani, Emanuele Bartolini, Marta D'Amora, Ugo Faraguna, Filippo Sean Giorgi

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. The Evolving ADHD Phenotype in the Externalizing Context.The American journal of psychiatry · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Alessandro GalganiDepartment of Translational Research and of New Surgical and Medical Technologies, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-1894-4128
Emanuele BartoliniDepartment of Developmental Neuroscience, IRCCS Fondazione Stella Maris, 56128 Pisa, Italy.ORCID 0000-0002-5683-1941
Marta D'AmoraDepartment of Biology, University of Pisa, 56125 Pisa, Italy.ORCID 0000-0001-6234-8078
Ugo FaragunaDepartment of Translational Research and of New Surgical and Medical Technologies, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-4814-7218
Filippo Sean GiorgiDepartment of Translational Research and of New Surgical and Medical Technologies, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-2940-8128
University of Pisa · ITFondazione Stella Maris · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this article is to highlight the potential role of the locus-coeruleus-noradrenergic (LC-NA) system in neurodevelopmental disorders (NdDs). The LC is the main brain noradrenergic nucleus, key in the regulation of arousal, attention, and stress response, and its early maturation and sensitivity to perinatal damage make it an interesting target for translational research. Clinical data shows the involvement of the LC-NA system in several NdDs, suggesting a pathogenetic role in the development of such disorders. In this context, a new neuroimaging tool, LC Magnetic Resonance Imaging (MRI), has been developed to visualize the LC in vivo and assess its integrity, which could be a valuable tool for exploring morphological alterations in NdD in vivo in humans. New animal models may be used to test the contribution of the LC-NA system to the pathogenic pathways of NdD and to evaluate the efficacy of NA-targeting drugs. In this narrative review, we provide an overview of how the LC-NA system may represent a common pathophysiological and pathogenic mechanism in NdD and a reliable target for symptomatic and disease-modifying drugs. Further research is needed to fully understand the interplay between the LC-NA system and NdD.

Indexed as

Neurodevelopmental DisordersNorepinephrineAnimalsArousalHumansLocus CoeruleusNorepinephrineADHDautismchildhood epilepsydevelopmental disorderslocus coeruleusneurodevelopmentneurogenesisneuropediatricnoradrenaline

Identifiers

PMID36982879
PMCPMC10055776
OpenAlexW4327966063

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.